Supplier to UK public sector

Napp Pharmaceuticals Ltd

Awarded 16 public-sector contracts across 6 buyers.

Active
16
Awards won
Reported value
6
Buyers
0
Spend payments

Napp Pharmaceuticals Ltd is a supplier to the UK public sector with 16 recorded contract awards. Below are the contracts it has won, the public bodies it works with, and its Companies House profile.

Company profile

Status
Active
Registered office
CAMBRIDGE
Buyers worked with
6
Total award value
Transparency spend

Contracts won

16 awards across the UK public sector.

ProcurementBuyerAwardedValue
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines - National TenderNHS England
NHS National Pharmaceuticals Transition 2022_1NHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS England

Buyers worked with

FAQs about Napp Pharmaceuticals Ltd

How many public-sector contracts has Napp Pharmaceuticals Ltd won?

Napp Pharmaceuticals Ltd has 16 recorded contract awards.

Which public bodies buy from Napp Pharmaceuticals Ltd?

Napp Pharmaceuticals Ltd has worked with 6 buyers, including NHS England, The NHS Commissioning Board (operating under the name of NHS England), NHS England, NHS England, NHS England, NHS England.

Is Napp Pharmaceuticals Ltd registered at Companies House?

Yes — NAPP PHARMACEUTICALS LIMITED is registered at Companies House under number 03690299 (status: Active).

Win more work like Napp Pharmaceuticals Ltd

Enable shows you who's buying, who's winning and where the pipeline is heading across UK public procurement. Talk to us about supplier intelligence.

Get in touch with Enable